A Case Report of A Patient of Iga Nephropathy Associated With Psoriasis: A Contribution To The Entity of ‘Psoriatic Nephropathy’

Manchanda, Bharat Veer

doi:10.9790/0853-1603040507

IOSR JDMS

2017

DOI: 10.9790/0853-1603040507

|View full text |Cite

A Case Report of A Patient of Iga Nephropathy Associated With Psoriasis: A Contribution To The Entity of ‘Psoriatic Nephropathy’

Bharat Veer Manchanda¹

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 3 publications

(3 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports

Tota

Baron

Musial

et al. 2023

JCM

View full text Add to dashboard Cite

Primary (pIgAN), secondary IgA nephropathy (sIgAN), and IgA-associated nephropathy can be distinguished. While pIgAN has been thoroughly studied, information about the etiology of sIgAN remains scarce. As concerns sIgAN, several studies suggest that different etiologic factors play a role and ultimately lead to a pathophysiologic process similar to that of pIgAN. In this article, we review a vast number of cases in order to determine the novel putative underlying diseases of sIgAN. Moreover, updates on the common pathophysiology of primary disorders and sIgAN are presented. We identified liver, gastrointestinal, oncological, dermatological, autoimmune, and respiratory diseases, as well as infectious, iatrogenic, and environmental factors, as triggers of sIgAN. As novel biological therapies for listed underlying diseases emerge, we suggest implementing drug-induced sIgAN as a new significant category. Clinicians should acknowledge the possibility of sIgAN progression in patients treated with TNF-α inhibitors, IL-12/IL-23-inhibitors, immune checkpoint inhibitors, CTLA-4, oral anticoagulants, thioureylene derivatives, and anti-vascular endothelial growth factor drugs.

show abstract

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports

Tota

Baron

Musial

et al. 2023

JCM

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

A Case Report of A Patient of Iga Nephropathy Associated With Psoriasis: A Contribution To The Entity of ‘Psoriatic Nephropathy’

Cited by 1 publication

References 3 publications

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports

Secondary IgA Nephropathy and IgA-Associated Nephropathy: A Systematic Review of Case Reports

Contact Info

Product

Resources

About